3 Recruiting Renal Cell Carcinoma Clinical Trials in District Of Columbia
Explore active renal cell carcinoma research studies enrolling across District Of Columbia. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Renal Cell Carcinoma Studies in District Of Columbia
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
📍 Local Institution - 0013 — Washington D.C., District of Columbia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
📍 Georgetown University Medical Center ( Site 1002) — Washington D.C., District of Columbia
View Study & Checklist ➔ 🟢 Recruiting Phase2 📋 Clinical Research Protocol
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔